158 related articles for article (PubMed ID: 8223852)
1. A new infectious mammary tumor virus in the milk of mice implanted with C4 hyperplastic alveolar nodules.
Shakhov AN; Wang H; Acha-Orbea H; Pauley RJ; Wei WZ
Eur J Immunol; 1993 Nov; 23(11):2765-9. PubMed ID: 8223852
[TBL] [Abstract][Full Text] [Related]
2. A V beta 8.2-specific superantigen from exogenous mouse mammary tumor virus carried by FM mice.
Yoshimoto T; Nagase H; Nakano H; Matsuzawa A; Nariuchi H
Eur J Immunol; 1994 Jul; 24(7):1612-9. PubMed ID: 7913038
[TBL] [Abstract][Full Text] [Related]
3. Activation of natural killer cells by mouse mammary tumor virus C4 in BALB/c and T-cell receptor V beta 2-transgenic mice.
Gill R; Wang H; Bluethmann H; Iglesias A; Wei WZ
Cancer Res; 1994 Mar; 54(6):1529-35. PubMed ID: 8137259
[TBL] [Abstract][Full Text] [Related]
4. New infectious mammary tumor virus superantigen with V beta-specificity identical to staphylococcal enterotoxin B (SEB).
Luther S; Shakhov AN; Xenarios I; Haga S; Imai S; Acha-Orbea H
Eur J Immunol; 1994 Aug; 24(8):1757-64. PubMed ID: 8056034
[TBL] [Abstract][Full Text] [Related]
5. Sequence similarity between the long terminal repeat coding regions of mammary-tumorigenic BALB/cV and renal-tumorigenic C3H-K strains of mouse mammary tumor virus.
Kang JJ; Schwegel T; Knepper JE
Virology; 1993 Sep; 196(1):303-8. PubMed ID: 8395120
[TBL] [Abstract][Full Text] [Related]
6. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H
J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017
[TBL] [Abstract][Full Text] [Related]
7. Concomitant infection with exogenous mouse mammary tumor virus encoding I-E-dependent superantigen in I-E-negative mouse strain.
Ando Y; Wajjwalku W; Niimi N; Hiromatsu K; Morishima T; Yoshikai Y
J Immunol; 1995 Jun; 154(12):6219-26. PubMed ID: 7759859
[TBL] [Abstract][Full Text] [Related]
8. Adoptive transfer of V beta 2-deleting activity with host cells from mice implanted with C4 preneoplastic hyperplastic alveolar nodules.
Wei WZ; Wang H; Ficsor-Jacobs R; Pauley R
Cancer Res; 1992 Oct; 52(19):5183-9. PubMed ID: 1327503
[TBL] [Abstract][Full Text] [Related]
9. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
Hodes RJ; Novick MB; Palmer LD; Knepper JE
J Immunol; 1993 Feb; 150(4):1422-8. PubMed ID: 8094408
[TBL] [Abstract][Full Text] [Related]
10. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
Maillard I; Erny K; Acha-Orbea H; Diggelmann H
Eur J Immunol; 1996 May; 26(5):1000-6. PubMed ID: 8647159
[TBL] [Abstract][Full Text] [Related]
11. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
Braun MY; Jouvin-Marche E; Marche PN; MacDonald HR; Acha-Orbea H
Eur J Immunol; 1995 Mar; 25(3):857-62. PubMed ID: 7705418
[TBL] [Abstract][Full Text] [Related]
12. B and T cells are required for mouse mammary tumor virus spread within the mammary gland.
Golovkina TV; Dudley JP; Ross SR
J Immunol; 1998 Sep; 161(5):2375-82. PubMed ID: 9725233
[TBL] [Abstract][Full Text] [Related]
13. Identification of an endogenous mammary tumor virus involved in the clonal deletion of V beta 2 T cells.
Jouvin-Marche E; Marche PN; Six A; Liebe-Gris C; Voegtle D; Cazenave PA
Eur J Immunol; 1993 Nov; 23(11):2758-64. PubMed ID: 8223851
[TBL] [Abstract][Full Text] [Related]
14. Deletion of CD4+ T cells and thymocytes by apoptosis in mouse mammary tumor virus (C4)-infected V beta 2 transgenic mice.
Wang H; Gill RF; Lichlyter D; Iglesias A; Bluethmann H; Wei WZ
Eur J Immunol; 1994 Dec; 24(12):2950-6. PubMed ID: 7805721
[TBL] [Abstract][Full Text] [Related]
15. Exogenous mouse mammary tumor virus (MMTV) infection induces endogenous MMTV sag expression.
Xu L; Wrona TJ; Dudley JP
Virology; 1996 Jan; 215(2):113-23. PubMed ID: 8560758
[TBL] [Abstract][Full Text] [Related]
16. Expression of mammary tumor virus proteins in preneoplastic outgrowth lines and mammary tumors of BALB/cV mice.
Slagle BL; Lanford RE; Medina D; Butel JS
Cancer Res; 1984 May; 44(5):2155-62. PubMed ID: 6324998
[TBL] [Abstract][Full Text] [Related]
17. Lobuloalveolar differentiation and tumorigenesis: two separate activities of mouse mammary tumor virus.
Squartini F; Basolo F; Bistocchi M
Cancer Res; 1983 Dec; 43(12 Pt 1):5879-82. PubMed ID: 6315219
[TBL] [Abstract][Full Text] [Related]
18. Endogenous superantigen expression controlled by a novel promoter in the MMTV long terminal repeat.
Günzburg WH; Heinemann F; Wintersperger S; Miethke T; Wagner H; Erfle V; Salmons B
Nature; 1993 Jul; 364(6433):154-8. PubMed ID: 8391646
[TBL] [Abstract][Full Text] [Related]
19. [Endogenous MMTV in the normal mammary gland and in dimethylanthracene-induced mammary cancer in BALB/c mice].
Komarova EA; Kriukova IN; Chernov MV; Kazarov AR
Mol Gen Mikrobiol Virusol; 1987 Aug; (8):10-3. PubMed ID: 2825005
[TBL] [Abstract][Full Text] [Related]
20. Elimination of V beta 2 bearing T-cells in BALB/c mice implanted with syngeneic preneoplastic and neoplastic mammary lesions.
Wei WZ; Ficsor-Jacobs R; Tsai SJ; Pauley R
Cancer Res; 1991 Jun; 51(12):3331-3. PubMed ID: 2040009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
